MedPath

Resident Memory T Cells in Vitiligo

Conditions
Vitiligo
Registration Number
NCT05223738
Lead Sponsor
Kasr El Aini Hospital
Brief Summary

This study aims to detect the presence and diversity of Tissue resident memory T cell populations in early and late cases of generalized non-segmental Vitiligo.

Detailed Description

* Written informed consent obtained from every participant.

* Detailed history taking including onset, course, duration of the disease, aggravating factors and received medications

* VASI score assessed in every patient.

* Patients photographed, divided into two groups early \& late cases and 3 mm punch biopsies will be taken from perilesional and non lesional skin.

* Biopsies processed and stained for CD8 \& CD69 in cases of early group, \& late group and controls by immunofluorescence.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
29
Inclusion Criteria
    • Patients with Generalized non-segmental Vitiligo ( lesions in more than one anatomical site ).
  • Both genders.
  • Early group: onset less than or equal 6 months.
  • Late group: onset more than 6 months
Exclusion Criteria
  • Localized or Segmental Vitiligo.
  • Age < 14 years.
  • Pregnant females
  • Patient who received treatment of any type within the last 3 months for the late group.
  • Patients with other skin diseases or immunosuppression

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Double CD8+ and CD69+ immunofluorescence6months-1 year

Number of Tissue resident Memory cells by double stained by CD8+ \&CD 69+ in early and late generalized non segmental vitiligo patients

CD69+ immunofluorescence6months-1 year

Number of Tissue resident Memory cells by positively stained by CD8+ in early and late generalized non segmental vitiligo patients

CD8+ immunofluorescence6months-1 year

Number of Tissue resident Memory cells by positively stained by CD8+ in early and late generalized non segmental vitiligo patients

VASI6months-1 year

Vitiligo Area and Severity index minimum 0 maximum 100, the larger the number the worse the condition

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Kasr El Ainy University hospital

🇪🇬

Cairo, Egypt

© Copyright 2025. All Rights Reserved by MedPath